Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jul 2014

Cui Jing, Li Dalu, Shen Liang, Zhang Wenmei, Xu Xin

Abstract excerpt

Several studies have investigated the association between xeroderma pigmentosum group D (XPD) Lys751Gln polymorphism and oral cancer. However, the impact of XPD Lys751Gln polymorphism on oral cancer risk is unclear, owing to the obvious inconsistence among those studies. The aim of this study was to derive a more precise estimation of the association of XPD Lys751Gln polymorphism with oral cancer by performing a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Genetic Association Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Mouth Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to White People

Share to Xeroderma Pigmentosum Group D Protein

Source

Identifiers

PMID: 24652592
DOI: 10.1007/s13277-014-1835-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.PMID 24652592Read ↗

Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.Semantic proximity Read ↗

Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects.Semantic proximity Read ↗

The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis.Semantic proximity Read ↗

XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.Semantic proximity Read ↗

XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis.Semantic proximity Read ↗

Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.Semantic proximity Read ↗

XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.Semantic proximity Read ↗

Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.Semantic proximity Read ↗

XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.Semantic proximity Read ↗

The association between XPD rs13181 and rs1799793 polymorphism and oral cancer risk: evidence from a meta-analysis.Semantic proximity Read ↗

XPD Lys751Gln polymorphism and esophageal cancer risk: a meta-analysis involving 2288 cases and 4096 controls.Semantic proximity Read ↗

XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.